Design Therapeutics Inc
NASDAQ:DSGN
Design Therapeutics Inc
NASDAQ:DSGN
Price:
4.77 USD
1.71%
Market Closed
Updated:
May 10, 2024
Design Therapeutics Inc
Total Other Income
|
Design Therapeutics Inc
Total Other Income Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Design Therapeutics Inc
NASDAQ:DSGN
|
Total Other Income
$11.3m
|
CAGR 3-Years
510%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Total Other Income
-$4.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-204%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Other Income
$252m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Other Income
$151m
|
CAGR 3-Years
126%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Other Income
-$15.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-61%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Other Income
-$31.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Design Therapeutics Inc's Total Other Income?
Total Other Income
11.3m
USD
11.3m
USD
Based on the financial report for Dec 31, 2023, Design Therapeutics Inc's Total Other Income amounts to 11.3m USD.
What is Design Therapeutics Inc's Total Other Income growth rate?
Total Other Income CAGR 3Y
510%
510%
Over the last year, the Total Other Income growth was 164%. The average annual Total Other Income growth rates for Design Therapeutics Inc have been 510% over the past three years .
You don't have any saved screeners yet
